Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan

Table 5

Multivariate analysis of the clinical factors influencing the efficacy of Helicobacter pylori eradication.

Clinical factor	Coefficient	Standard error	Odds ratio; (95% CI)	𝑃 value
Duration of; H.  pylori eradication; (10 days versus 14 days)	1.38	0.46	3.98 (1.60–9.86)	0.003

EAL-10: esomeprazole/amoxicillin/levofloxacin triple therapy × 10 days and EAL-14: esomeprazole/amoxicillin/levofloxacin triple therapy × 14 days.